Clinical and Imaging Characteristics in Patients with SARS-CoV-2 Infection and Acute Intracranial Hemorrhage
暂无分享,去创建一个
M. Wildgruber | G. Boulouis | G. Thomalla | A. Morotti | B. Hamm | J. Fiehler | M. Psychogios | H. Kniep | J. Nawabi | U. Hanning | P. Sporns | F. Schlunk | E. Can | H. Kraehling
[1] Bernd Weissmuller,et al. Trials , 2020, Israelpolitik.
[2] M. Versino,et al. Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient , 2020, Journal of Neurology.
[3] R. Garg,et al. Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline , 2020, Journal of the Neurological Sciences.
[4] L. Saba,et al. Imaging of Neurologic Disease in Hospitalized Patients with COVID-19: An Italian Multicenter Retrospective Observational Study , 2020, Radiology.
[5] H. Kamel,et al. Risk of Ischemic Stroke in Patients with Covid-19 versus Patients with Influenza , 2020, medRxiv.
[6] M. Castillo,et al. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection , 2020, American Journal of Neuroradiology.
[7] Julie G. Burel,et al. Mechanical Thrombectomy for Acute Ischemic Stroke Amid the COVID-19 Outbreak , 2020, Stroke.
[8] Angelo Mazza,et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study , 2020, The Lancet.
[9] N. O'Connell,et al. COVID19 coagulopathy in Caucasian patients , 2020, British journal of haematology.
[10] Holger Moch,et al. Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.
[11] E. Andrès,et al. Immune Thrombocytopenic Purpura in a Patient with Covid-19 , 2020, The New England journal of medicine.
[12] B. Liang,et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis , 2020, Journal of Infection.
[13] L. Mao,et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. , 2020, JAMA neurology.
[14] S. Maskatia,et al. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. , 2020, Hospital pediatrics.
[15] G. Lippi,et al. D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis , 2020, Thrombosis and Haemostasis.
[16] L. Mao,et al. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists , 2020, Stroke and vascular neurology.
[17] C. Eastin,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The Journal of Emergency Medicine.
[18] Amaryllis Mavragani,et al. Tracking COVID-19 in Europe: Infodemiology Approach , 2020, JMIR public health and surveillance.
[19] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[20] A. Sweidan,et al. Coagulopathy reversal in intracerebral haemorrhage , 2020, Stroke & Vascular Neurology.
[21] P. Coyle,et al. Central Nervous System Vasculitis due to Infection. , 2019, Neurologic clinics.
[22] S. Blackburn,et al. Endothelial Cell Dysfunction and Injury in Subarachnoid Hemorrhage , 2018, Molecular Neurobiology.
[23] E. Fan,et al. Intracranial hemorrhage in adults on ECMO , 2018, Perfusion.
[24] R. Gerraty,et al. Cerebral amyloid angiopathy: Review of clinico‐radiological features and mimics , 2018, Journal of medical imaging and radiation oncology.
[25] T. Kiehl,et al. Critical Illness–Associated Cerebral Microbleeds , 2017, Stroke.
[26] O. Naggara,et al. Primary Angiitis of the Central Nervous System: Magnetic Resonance Imaging Spectrum of Parenchymal, Meningeal, and Vascular Lesions at Baseline , 2017, Stroke.
[27] M. Barboza,et al. Reversible cerebral vasoconstriction syndrome and nonaneurysmal subarachnoid hemorrhage. , 2014, Journal of vascular and interventional neurology.
[28] G. Hunder,et al. Adult primary central nervous system vasculitis , 2012, The Lancet.
[29] S. Zeiler,et al. Diagnosing CNS Vasculitis: The Case Against Empiric Treatment , 2012, The neurologist.
[30] G. Hunder,et al. Adult primary central nervous system vasculitis: an update , 2012, Current opinion in rheumatology.
[31] G. Hunder,et al. Primary central nervous system vasculitis presenting with intracranial hemorrhage. , 2011, Arthritis and rheumatism.
[32] V. Larrue,et al. Isolated Acute Nontraumatic Cortical Subarachnoid Hemorrhage , 2010, American Journal of Neuroradiology.
[33] C. Anderson,et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2010, Stroke.
[34] J. Penninger,et al. SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS , 2009, European journal of clinical investigation.
[35] A. Adebajo,et al. Virus-induced vasculitis , 2008, Current rheumatology reports.
[36] G. Navis,et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.
[37] R. Jain,et al. Varicella-zoster vasculitis presenting with intracranial hemorrhage. , 2003, AJNR. American journal of neuroradiology.
[38] Amir Lerman,et al. Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[39] A. Ropper,et al. Intracranial pressure monitoring in comatose patients with cerebral hemorrhage. , 1984, Archives of neurology.
[40] C. E.. WHO Coronavirus Disease (COVID-19) Dashboard , 2020 .
[41] J. Broderick,et al. Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials. , 2017, Stroke.
[42] R. Grossman,et al. Cerebral vasculitis: MR imaging and angiographic correlation. , 1992, Radiology.